menutranslate
Schedule Your Appointment Today

Clinical Research

BreatheAmerica Clinical Research

BreatheAmerica is committed to improving the quality of care for its patients and their families and part of that commitment means offering our patients the opportunity to participate in clinical trials.

What is a clinical trial?

A clinical trial is a research study designed to answer specific health questions. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people and ways to improve health.

Why participate in a clinical trial?

Volunteers in clinical trials can play a more active role in their own health care, get access to new research treatments before they are widely available, and help others by contributing to medical science.

Who can participate in a clinical trial?

All clinical trials have guidelines about who can participate. These guidelines are based on things like age, gender, medical history and the types of medications you may be taking. There are clinical trials for adults, children, healthy volunteers and people who have a specific medical condition. Ask your provider if there is a clinical trial that is right for you.

Current Research Opportunities

Whether you are looking for treatment options or just want to help further the advancement of treatment, diagnosis, and prevention, there are studies out there who need you. BreatheAmerica is actively looking for patients diagnosed with any of the following:

Allergies

A Phase III, Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-3641, a Ragweed (Ambrosia artemisiifolia) Sublingual Immunotherapy Tablet, in Children With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma

This study is looking for volunteers who meet the following criteria:

  • Between the ages of 4 and 17 years old
  • Have a history of ragweed allergy
  • Has never been treated with Xoliar
  • Has not received immunotherapy shots within the last 5 years

Contacts and Locations:

Shreveport: Shannon Saksa


IVORY: HypoallergenIcity eValuation Of a new extensively hydRolYzed formula

This study is looking for volunteers who meet the following criteria:

  • Between the ages of 2 months and 4 years old
  • History of allergy to cow’s milk
  • Not currently breastfeeding

Contacts and Locations:

Albuquerque: Laura Jones

Asthma

A Multicenter, Randomized, Double-blind, Parallel Group, Placebocontrolled, Phase 3b Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients with Severe Asthma Uncontrolled on Standard of Care Treatment (ANDHI)

This study is looking for volunteers who meet the following criteria:

  • Over the age of 18
  • Have a history of severe asthma
  • Do not have any other pulmonary diseases like COPD
  • Currently taking a high-dose inhaled corticosteroid

Contacts and Locations:

Shreveport: Shannon Saksa

Albuquerque: Laura Jones


An 8-week, randomized, double-blind, placebo and active-controlled, parallel group, dose ranging study to evaluate the efficacy and safety of 3 doses of CHF 718 pMDI (beclomethasone dipropionate) in asthmatic subjects

This study is looking for volunteers who meet the following criteria:

  • Over the age of 18
  • Have a history of asthma
  • Currently taking a inhaled corticosteroid

Contacts and Locations:

Albuquerque: Laura Jones


Observational study of obstructive lung disease (NOVELTY)

This study is looking for volunteers who meet the following criteria:

  • 12 years old or older
  • Have a history of asthma

Contacts and Locations:

Shreveport: Shannon Saksa

Albuquerque: Laura Jones

COPD

 Observational Cohort Study to Quantify the Incidence and Comparative Safety of Selected Cardiovascular and Cerebrovascular Events in COPD Patients Using Inhaled UMEC/VI Combination or Inhaled UMEC versus Tiotropium (COPD PASS)

This study is looking for volunteers who meet the following criteria:

  • Adults 18 years or older
  • History of COPD

Contacts and Locations:

Shreveport: Shannon Saksa

 

Chronic Cough

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Month Study to Evaluate the Efficacy and Safety of MK-7264 in Adult Participants with Chronic Cough (PN027)

This study is looking for volunteers who meet the following criteria:

  • Adults 18 years or older
  • History of Chronic Cough longer than 1 year
  • Non-Smokers or Ex-Smokers with more than 12 months of non-smoking history

Contacts and Locations:

Shreveport: Shannon Saksa

Hereditary Angioedema (HAE)

Coming Soon

Pulmonary Hypertension

Coming Soon

Sinusitis (Sinus Infections)

Coming Soon